サマリー

頭頸部癌治療の世界市場 2023-2027
頭頸部癌治療市場は2022-2027年に5077.38百万米ドルの成長が予測され、予測期間中のCAGRは11.27%で加速すると予測されています。当レポートでは、頭頸部癌治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、頭頸部がんの罹患率の増加、高齢者人口の増加、がん関連イニシアチブの増加によって牽引されています。
Technavioの頭頸部がん治療市場は以下のように区分される：
投与経路別
- 注射剤
- 経口剤
治療法別
- 免疫療法
- 標的療法
- 化学療法
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、診断と治療における技術の進歩が、今後数年間の頭頸部がん治療市場の成長を促進する主要な理由の1つであると特定している。また、低侵襲手術に対する需要の高まりや、腫瘍学関連の医療ツーリズムの傾向の高まりは、市場の大きな需要につながる。
本レポートでは、頭頸部癌治療市場について以下の領域をカバーしています：
- 頭頸部がん治療市場のサイジング
- 頭頸部がん治療市場予測
- 頭頸部がん治療市場の分析
Inc.、ノバルティスAG、ファイザーInc.、サノフィ。また、頭頸部癌治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/head-and-neck-cancer-treatment-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global head and neck cancer treatment market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global head and neck cancer treatment market 2017 - 2021 ($ million)
o 4.2 Route of Administration Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
o 4.3 Therapy Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Injectable - Market size and forecast 2022-2027
o Exhibit 34: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Injectable - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
o 6.4 Oral - Market size and forecast 2022-2027
o Exhibit 38: Chart on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Oral - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Oral - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Route of Administration
o Exhibit 42: Market opportunity by Route of Administration ($ million)
o Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)
• 7 Market Segmentation by Therapy
o 7.1 Market segments
o Exhibit 44: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Therapy - Market share 2022-2027 (%)
o 7.2 Comparison by Therapy
o Exhibit 46: Chart on Comparison by Therapy
o Exhibit 47: Data Table on Comparison by Therapy
o 7.3 Immunotherapy - Market size and forecast 2022-2027
o Exhibit 48: Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
o 7.4 Targeted therapy - Market size and forecast 2022-2027
o Exhibit 52: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
o 7.5 Chemotherapy - Market size and forecast 2022-2027
o Exhibit 56: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Therapy
o Exhibit 60: Market opportunity by Therapy ($ million)
o Exhibit 61: Data Table on Market opportunity by Therapy ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2022-2027 (%)
o Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 111: Amgen Inc. - Overview
o Exhibit 112: Amgen Inc. - Product / Service
o Exhibit 113: Amgen Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 114: AstraZeneca Plc - Overview
o Exhibit 115: AstraZeneca Plc - Product / Service
o Exhibit 116: AstraZeneca Plc - Key news
o Exhibit 117: AstraZeneca Plc - Key offerings
o 12.5 Ayala Pharmaceuticals Inc.
o Exhibit 118: Ayala Pharmaceuticals Inc. - Overview
o Exhibit 119: Ayala Pharmaceuticals Inc. - Product / Service
o Exhibit 120: Ayala Pharmaceuticals Inc. - Key offerings
o 12.6 Bristol Myers Squibb Co.
o Exhibit 121: Bristol Myers Squibb Co. - Overview
o Exhibit 122: Bristol Myers Squibb Co. - Product / Service
o Exhibit 123: Bristol Myers Squibb Co. - Key news
o Exhibit 124: Bristol Myers Squibb Co. - Key offerings
o 12.7 Debiopharm International SA
o Exhibit 125: Debiopharm International SA - Overview
o Exhibit 126: Debiopharm International SA - Product / Service
o Exhibit 127: Debiopharm International SA - Key news
o Exhibit 128: Debiopharm International SA - Key offerings
o 12.8 Eli Lilly and Co.
o Exhibit 129: Eli Lilly and Co. - Overview
o Exhibit 130: Eli Lilly and Co. - Product / Service
o Exhibit 131: Eli Lilly and Co. - Key news
o Exhibit 132: Eli Lilly and Co. - Key offerings
o 12.9 Incyte Corp.
o Exhibit 133: Incyte Corp. - Overview
o Exhibit 134: Incyte Corp. - Product / Service
o Exhibit 135: Incyte Corp. - Key offerings
o 12.10 Merck and Co. Inc.
o Exhibit 136: Merck and Co. Inc. - Overview
o Exhibit 137: Merck and Co. Inc. - Business segments
o Exhibit 138: Merck and Co. Inc. - Key news
o Exhibit 139: Merck and Co. Inc. - Key offerings
o Exhibit 140: Merck and Co. Inc. - Segment focus
o 12.11 Novartis AG
o Exhibit 141: Novartis AG - Overview
o Exhibit 142: Novartis AG - Business segments
o Exhibit 143: Novartis AG - Key offerings
o Exhibit 144: Novartis AG - Segment focus
o 12.12 Pfizer Inc.
o Exhibit 145: Pfizer Inc. - Overview
o Exhibit 146: Pfizer Inc. - Product / Service
o Exhibit 147: Pfizer Inc. - Key news
o Exhibit 148: Pfizer Inc. - Key offerings
o 12.13 Sanofi
o Exhibit 149: Sanofi - Overview
o Exhibit 150: Sanofi - Business segments
o Exhibit 151: Sanofi - Key news
o Exhibit 152: Sanofi - Key offerings
o Exhibit 153: Sanofi - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 154: Inclusions checklist
o Exhibit 155: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 156: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 157: Research methodology
o Exhibit 158: Validation techniques employed for market sizing
o Exhibit 159: Information sources
o 13.5 List of abbreviations
o Exhibit 160: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global head and neck cancer treatment market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Therapy Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Therapy - Market share 2022-2027 (%)
Exhibits45: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Therapy
Exhibits47: Data Table on Comparison by Therapy
Exhibits48: Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Therapy ($ million)
Exhibits61: Data Table on Market opportunity by Therapy ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2022-2027 (%)
Exhibits64: Data Table on Market share by geography 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Amgen Inc. - Overview
Exhibits112: Amgen Inc. - Product / Service
Exhibits113: Amgen Inc. - Key offerings
Exhibits114: AstraZeneca Plc - Overview
Exhibits115: AstraZeneca Plc - Product / Service
Exhibits116: AstraZeneca Plc - Key news
Exhibits117: AstraZeneca Plc - Key offerings
Exhibits118: Ayala Pharmaceuticals Inc. - Overview
Exhibits119: Ayala Pharmaceuticals Inc. - Product / Service
Exhibits120: Ayala Pharmaceuticals Inc. - Key offerings
Exhibits121: Bristol Myers Squibb Co. - Overview
Exhibits122: Bristol Myers Squibb Co. - Product / Service
Exhibits123: Bristol Myers Squibb Co. - Key news
Exhibits124: Bristol Myers Squibb Co. - Key offerings
Exhibits125: Debiopharm International SA - Overview
Exhibits126: Debiopharm International SA - Product / Service
Exhibits127: Debiopharm International SA - Key news
Exhibits128: Debiopharm International SA - Key offerings
Exhibits129: Eli Lilly and Co. - Overview
Exhibits130: Eli Lilly and Co. - Product / Service
Exhibits131: Eli Lilly and Co. - Key news
Exhibits132: Eli Lilly and Co. - Key offerings
Exhibits133: Incyte Corp. - Overview
Exhibits134: Incyte Corp. - Product / Service
Exhibits135: Incyte Corp. - Key offerings
Exhibits136: Merck and Co. Inc. - Overview
Exhibits137: Merck and Co. Inc. - Business segments
Exhibits138: Merck and Co. Inc. - Key news
Exhibits139: Merck and Co. Inc. - Key offerings
Exhibits140: Merck and Co. Inc. - Segment focus
Exhibits141: Novartis AG - Overview
Exhibits142: Novartis AG - Business segments
Exhibits143: Novartis AG - Key offerings
Exhibits144: Novartis AG - Segment focus
Exhibits145: Pfizer Inc. - Overview
Exhibits146: Pfizer Inc. - Product / Service
Exhibits147: Pfizer Inc. - Key news
Exhibits148: Pfizer Inc. - Key offerings
Exhibits149: Sanofi - Overview
Exhibits150: Sanofi - Business segments
Exhibits151: Sanofi - Key news
Exhibits152: Sanofi - Key offerings
Exhibits153: Sanofi - Segment focus
Exhibits154: Inclusions checklist
Exhibits155: Exclusions checklist
Exhibits156: Currency conversion rates for US$
Exhibits157: Research methodology
Exhibits158: Validation techniques employed for market sizing
Exhibits159: Information sources
Exhibits160: List of abbreviations